Use of a negative pressure procedural tent in the Emergency Department during the COVID-19 pandemic Clinicians in Emergency Departments (EDs) face unprecedented and unparalleled risks during the COVID-19 pandemic [1]. Many healthcare systems continue to face challenges posed by ED overcrowding and boarding of critically ill patients due to limited inpatient capacity [2]. Aerosol generating procedures (AGPs), including non-invasive ventilation (NIV), oxygen delivery via high flow nasal cannula (HFNC), nebulized medication therapy, and endotracheal intubation, are frequently performed in EDs in patients with respiratory distress and respiratory failure. AGPs must be performed in the ED on COVID positive patients or patients with unknown COVID status due to the emergent and unplanned nature of the patient's arrival and need for resuscitative therapies. AGPs have been associated with higher rates of viral transmission to healthcare workers [3], and allocating appropriate and timely personal protective equipment (PPE) and negative pressure rooms is required to mitigate this risk. During the COVID-19 pandemic, PPE shortages exist and negative pressure rooms may be unavailable at the time an emergent AGP is required in the ED.To help mitigate these risks, efforts have been undertaken to rapidly develop devices and extensions of traditional PPE to better protect healthcare workers. Many of these innovations have had significant limitations, including limited scope and clinical applicability (ie, "intubation boxes" suited only for endotracheal intubation), mechanical limitations (heavy, inflexible, non-disposable with risk of patient to patient transmission), risks of damaging PPE, and limited adjustability preventing wide use for differing procedures and proceduralists. In one simulation, passive enclosures failed to contain aerosols, whereas the addition of a vacuum and air filtration contributed to reduced aerosol transmission [4]. Protective barrier enclosures without negative pressure have appeared ineffective in decreasing healthcare worker exposure, and instead appear to possibly contribute to increased healthcare worker exposure to airborne particles, resulting in the United States Food & Drug Administration revoking an Emergency Use Authorization that had previously supported their use [5].Initial pre-clinical testing and clinical use of a negative pressure procedural tent that mitigates the aforementioned device limitations (Fig. 1) has been previously described, demonstrating the ability to keep particle counts (0.01 μm to >1 μm) at ambient levels during AGPs [6]. The negative pressure procedural tent was developed collaboratively across disciplines (medicine and engineering) at the University of Michigan in collaboration with industry. It was designed to allow healthcare workers separation and protection from aerosols and respiratory droplets while supporting a wide range of procedures including AGPs. Room air is pulled through the tent by a fan with air exiting the tent through a HEPA filter prior to release ...